(Q41579447)

4 October 2017

title

Applicability of the EORTC/MSG criteria for IFD in clinical practice (English)

1 reference

4 October 2017

H Rieger

1 reference

4 October 2017

D Lustig

1 reference

4 October 2017

S Barlow

1 reference

4 October 2017

H Ostermann

1 reference

4 October 2017

M Fiegl

1 reference

4 October 2017

L Peterson

1 reference

4 October 2017

Christina T Rieger

1 reference

4 October 2017

publication date

30 December 2014

1 reference

4 October 2017

1 reference

4 October 2017

1 reference

4 October 2017

1 reference

4 October 2017

page(s)

847-855

1 reference

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

The radiological spectrum of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

[The halo sign in computed tomography images: differential diagnosis and correlation with pathology findings].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Advances and challenges in management of invasive mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Airway and parenchymal manifestations of pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2282-Y

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1007/S00277-014-2282-Y

1 reference

4 October 2017

1 reference